 |
US:
(339)-368-6001 |
| Intl.:
+1-339-368-6001 |
|
|
| |
|
|
|
|
|
|
US demand to reach $16.4 billion in 2012
US demand for cardiac implants will increase 8.8 percent annually to $16.4 billion in 2012. Evolving demographic and epidemiological patterns, along with the introduction of new and improved products, will promote growth. Based on aging population trends, the number of persons afflicted with one or more heart conditions is forecast to reach 73 million in 2012, up 1.7 percent per year from 2007. Implants are more effective than pharmaceuticals in treating, managing or preventing such cardiovascular disorders as arrhythmias, congestive heart failure, myocardial infarction, peripheral artery disease, stroke and valvular heart disease.
The market for cardiac implants is expected to recover from a sharp decline in coronary drug-eluting stent sales that began in mid-2006 and continued into the fourth quarter of 2007. This decline was due to a number of reports that linked the devices to a slightly greater risk of thrombosis in some post-angioplasty patients. Although the reported risk was only onehalf of one percent greater than for heart patients who received alternative therapies (i.e., angioplasty with bare-metal stents, coronary bypass surgery, medications), it prompted many physicians to discontinue using drug-eluting stents. This trend will change as new generation drug-eluting stents with smaller struts and a greatly reduced risk of complications reach the market over the next year.
Please Note: Freedonia requires that, for PDF orders, clients sign a confidentiality agreement prior to fulfillment of PDF email delivery.
|
|
- INTRODUCTION
- I. EXECUTIVE SUMMARY
- II. MARKET ENVIRONMENT
- General
- Macroeconomic Trends
- Demographic Patterns
- Health Insurance Trends
- Medical Conditions
- Acute Conditions
- Chronic Conditions
- National Health Expenditures
- Medical Providers
- Acute Care Hospitals
- Outpatient Clinics
- Skilled Nursing Homes
- Physicians
- Home Health Care Organizations
- Patient Activity
- Acute Care Hospital Admissions
- Surgical Procedures
- Outpatient Episodes
- Home Health Care Visits
- Medical Product Markets
- III. CARDIAC IMPLANT OVERVIEW
- General
- Cardiovascular Conditions
- Coronary Heart Disease
- Heart Rhythm Disorders
- Peripheral Arterial Disease (PAD)
- Valvular Heart Disease
- Stroke
- Congestive Heart Failure (CHF)
- Congenital Heart Defects
- Cardiac Implant Procedures
- Cardiac Implant Market Trends
- Regulatory Factors
- Demand Patterns
- Product Groups
- Indications
- US Trade
- International Markets
- IV. PACING DEVICES
- General
- Demand Patterns & Projections
- Producers & Market Share
- Implantable Cardioverter Defibrillators (ICDs)
- Technology
- Components & Design
- Functions
- Clinical Data
- Producers & Products
- Medtronic
- Boston Scientific
- St. Jude Medical
- Cardiac Resynchronization Therapy (CRT) Devices
- Technology
- Producers & Products
- Implantable Cardiac Pacemakers (ICPs)
- Technology
- Producers & Products
- Medtronic
- St. Jude Medical
- Boston Scientific
- Pacing Leads
- Technology
- Producers & Products
- Pacemaker Leads
- ICD Leads
- CRT Leads
- Pacing Device Batteries
- V. CARDIAC STENTS & RELATED IMPLANTS
- General
- Demand Patterns & Projections
- Producers & Market Share
- Coronary Stents
- Drug-Eluting Stents
- Bare-Metal Stents
- Peripheral Stents
- Endovascular Stent-Grafts
- Medtronic
- ANCURE
- Other Endovascular Stent-Grafts
- Renal & Related Stents
- Femoral & Related Stents
- Carotid Stents
- Stent-Related Implants
- Synthetic Grafts
- Vascular Grafts
- Peripheral Grafts
- Vena Cava Filters
- VI. STRUCTURAL CARDIAC IMPLANTS
- General
- Demand Patterns & Projections
- Producers & Market Share
- Heart Valves & Accessories
- Product Overview
- Tissue Heart Valves
- Types of Tissue Heart Valves
- Producers & Products
- Mechanical Heart Valves
- Design
- Producers & Products
- Heart Valve Repair Products
- Ventricular-Assist Devices
- Technology
- Producers & Products
- Implantable Heart Monitors
- Insertable Loop Recorders (ILRs)
- Implantable Hemodynamic Monitors
- VII. INDUSTRY STRUCTURE
- General
- Market Share
- Competitive Strategies
- Mergers & Acquisitions
- Licensing & Related Agreements
- Research & Development
- Marketing & Distribution
- Manufacturing Activities
- Company Profiles
- Abbott Laboratories
- Abiomed Incorporated
- Angiotech Pharmaceuticals Incorporated
- Arbor Surgical Technologies Incorporated
- Bard (CR) Incorporated
- Biophan Technologies Incorporated
- Boston Scientific Corporation
- Braun (B.) Melsungen AG
- CarboMedics Incorporated, see Sorin SpA
- Conor Medsystems LLC, see Johnson & Johnson
- Cook Group Incorporated
- Cordis Corporation, see Johnson & Johnson
- Core Valve Incorporated
- Edwards Lifesciences Corporation
- Endologix Incorporated
- Gore (WL) & Associates Incorporated
- Johnson & Johnson
- Medtronic Incorporated
- Myotech LLC, see Biophan Technologies Incorporated
- Sorin SpA
- St. Jude Medical Incorporated
- Terumo Corporation
- Thoratec Corporation
- Ventracor Limited
- LIST OF TABLES
- SECTION I -- EXECUTIVE SUMMARY
- Summary Table
- SECTION II -- MARKET ENVIRONMENT
- 1 Macroeconomic Indicators
- 2 Population by Age Group
- 3 Health Insurance Coverage of the US Population
- 4 Acute Conditions by Type
- 5 Chronic Conditions by Type
- 6 National Health Expenditures by Type & Source
- 7 Medical Providers by Type
- 8 Patient Activity by Type
- 9 Medical Product Demand
- SECTION III -- CARDIAC IMPLANT OVERVIEW
- 1 Cardiac Implant Market Indicators
- 2 Cardiovascular Conditions by Type
- 3 Cardiac Implant Procedures by Type
- 4 Cardiac Implant Market, 1997-2007
- 5 Cardiac Implant Demand by Product Group
- 6 Cardiac Implant Demand by Indication
- 7 US Trade in Cardiac Implants
- 8 World Cardiac Implant Demand by Region
- SECTION IV -- PACING DEVICES
- 1 Pacing Device Demand by Product Group
- 2 Implantable Cardioverter Defibrillator (ICD) Demand by Type
- 3 Cardiac Resynchronization Therapy (CRT) Device Demand
- 4 Implantable Cardiac Pacemaker Demand by Type
- 5 Pacing Lead Demand by Type
- SECTION V -- STENTS & RELATED IMPLANTS
- 1 Cardiac Stent & Related Implant Demand by Product Group
- 2 Coronary Stent Demand by Type
- 3 Coronary Drug-Eluting Stent Demand
- 4 Coronary Bare-Metal Stent Demand
- 5 Peripheral Stent Demand by Product Group
- 6 Endovascular Stent-Graft Demand
- 7 Renal & Related Stent Demand
- 8 Femoral & Related Stent Demand
- 9 Carotid Stent Demand
- 10 Stent-Related Implant Demand by Product Group
- SECTION VI -- STRUCTURAL CARDIAC IMPLANTS
- 1 Structural Cardiac Implant Demand by Product Group
- 2 Heart Valve Implant Demand by Product Group
- 3 Ventricular Assist Device Demand
- 4 Implantable Heart Monitor Demand
- SECTION VII -- INDUSTRY STRUCTURE
- 1 Cardiac Implant Sales by Company, 2007
- 2 Selected Acquisitions & Divestitures
- 3 Selected Cooperative Agreements
- LIST OF CHARTS
- SECTION III -- CARDIAC IMPLANT OVERVIEW
- 1 Cardiovascular Conditions by Type, 2007
- 2 Cardiac Implant Procedures by Type, 2007
- 3 Cardiac Implant Demand by Product Group, 2007
- 4 Cardiac Implant Demand by Indication, 2007
- SECTION IV -- PACING DEVICES
- 1 Pacing Device Demand by Product Group, 2007
- 2 Pacing Devices Market Share by Company, 2007
- SECTION V -- STENTS & RELATED IMPLANTS
- 1 Stent & Stent-Related Implant Demand by Product Group, 2007
- 2 Stents & Stent-Related Implant Market Share by Company, 2007
- SECTION VI -- STRUCTURAL CARDIAC IMPLANTS
- 1 Structural Cardiac Implant Demand by Product Group, 2007
- 2 Structural Cardiac Implant Market Share by Company, 2007
- SECTION VII -- INDUSTRY STRUCTURE
- 1 US Cardiac Implants, Market Share by Company, 2007
More Details
ICDs, CRT devices will remain dominant types
Cardiac implants extend into several product groups. Implantable cardioverter defibrillators (ICDs) and related cardiac resynchronization therapy (CRT) devices together with their accessories generate the largest demand, followed by various types of stents. These two product groups will continue to lead cardiac implant sales based on new product introductions, widening eligibility for private and public health insurance coverage, expanding numbers of new patients, and diminishing safety concerns. Providing the most effective therapy for bradycardia, pacemakers and accessories will continue to serve a large, expanding US market. However, growth opportunities for these devices will decelerate over the long term as they have already achieved a high level of market penetration.
Heart-related grafts will provide strong growth opportunities as improvements in stenting systems create new safe and effective devices for treating aortic aneurysms, peripheral arterial diseases and stroke. Demand for heart valves will benefit from advances in tissue engineering, which will improve the safety, performance and longevity of animalderived xenografts. Heart valve repair products, consisting of annuloplasty rings and bands, will also fare well in the marketplace as new cardiac diagnostics enable valvular heart diseases to be detected in earlier stages before complete valve replacement becomes necessary. Less favorably, strong growth in the market for tissue valves and valve repair products will be partially offset by decreasing sales of mechanical valves.
Demand for embolic protection devices will rise at a strong pace as many more heart patients undergo procedures that pose an elevated risk of deep vein thrombosis and embolisms. The market for ventricular-assist devices will continue to grow moderately, spurred by widening applications in the management of pretransplant and late-stage heart conditions. Based on their ability to detect heart attack symptoms earlier and save lives, implantable heart monitors will register strong sales growth over the long term.
Study coverage
Cardiac Implants is a new Freedonia industry study available for $4500. It presents historical demand data (1997, 2002, 2007) plus forecasts for 2012 and 2017 for cardiac implant products by type and indication. The study also assesses evolving research and development, details company market shares and profiles 20 competitors in the US industry.
|
|
|
